XML 37 R23.htm IDEA: XBRL DOCUMENT
v3.25.2

Valuation (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2025
Fair Value Disclosures [Abstract] |
Schedule of Fair Value Measurements | The following tables present the Company's financial instruments measured at fair value on: March 31, 2025:
(In thousands) |  |  |  |  |  |  |  |
Description |  | Level 1 |  | Level 2 |  | Level 3 |  | Total
Assets: |  |  |  |  |  |  |  |
Securities: |  |  |  |  |  |  |  |
CLOs |  | $ | — |  |  | $ | 116,434 |  |  | $ | 133,423 |  |  | $ | 249,857 |
Corporate debt |  | — |  |  | — |  |  | 434 |  |  | 434 |
Corporate equity |  | — |  |  | — |  |  | 56 |  |  | 56 |
Agency RMBS: |  |  |  |  |  |  |  |
30-year fixed-rate mortgages |  | — |  |  | 503,892 |  |  | — |  |  | 503,892 |
Interest only securities |  | — |  |  | — |  |  | 2 |  |  | 2 |
Total securities, at fair value |  | — |  |  | 620,326 |  |  | 133,915 |  |  | 754,241 |
Financial derivatives–assets, at fair value: |  |  |  |  |  |  |  |
TBAs |  | — |  |  | 138 |  |  | — |  |  | 138 |
Interest rate swaps |  | — |  |  | 181 |  |  | — |  |  | 181 |
Futures |  | 157 |  |  | — |  |  | — |  |  | 157 |
Credit default swaps |  | — |  |  | — |  |  | — |  |  | — |
Forwards |  | — |  |  | — |  |  | — |  |  | — |
Total financial derivatives–assets, at fair value |  | 157 |  |  | 319 |  |  | — |  |  | 476 |
Total securities and financial derivatives–assets, at fair value |  | 157 |  |  | 620,645 |  |  | 133,915 |  |  | 754,717 |
Liabilities: |  |  |  |  |  |  |  |
Financial derivatives–liabilities, at fair value: |  |  |  |  |  |  |  |
TBAs |  | — |  |  | (282) |  |  | — |  |  | (282) |
Interest rate swaps |  | — |  |  | (187) |  |  | — |  |  | (187) |
Futures |  | — |  |  | — |  |  | — |  |  | — |
Credit default swaps |  | — |  |  | (488) |  |  | — |  |  | (488) |
Total financial derivatives–liabilities, at fair value |  | $ | — |  |  | $ | (957) |  |  | $ | — |  |  | $ | (957) |
December 31, 2024:
(In thousands) |  |  |  |  |  |  |  |
Description |  | Level 1 |  | Level 2 |  | Level 3 |  | Total
Assets: |  |  |  |  |  |  |  |
Securities: |  |  |  |  |  |  |  |
CLOs |  | $ | — |  |  | $ | 67,498 |  |  | $ | 103,624 |  |  | $ | 171,122 |
Corporate debt |  | — |  |  | — |  |  | 428 |  |  | 428 |
Corporate equity |  | — |  |  | — |  |  | 56 |  |  | 56 |
Agency RMBS: |  |  |  |  |  |  |  |
30-year fixed-rate mortgages |  | — |  |  | 512,307 |  |  | — |  |  | 512,307 |
Interest only securities |  | — |  |  | — |  |  | 2 |  |  | 2 |
Total securities, at fair value |  | — |  |  | 579,805 |  |  | 104,110 |  |  | 683,915 |
Financial derivatives–assets, at fair value: |  |  |  |  |  |  |  |
TBAs |  | — |  |  | 592 |  |  | — |  |  | 592 |
Interest rate swaps |  | — |  |  | 40,317 |  |  | — |  |  | 40,317 |
Futures |  | 170 |  |  | — |  |  | — |  |  | 170 |
Credit default swaps |  | — |  |  | 705 |  |  | — |  |  | 705 |
Forwards |  | — |  |  | 83 |  |  | — |  |  | 83 |
Total financial derivatives–assets, at fair value |  | 170 |  |  | 41,697 |  |  | — |  |  | 41,867 |
Total securities and financial derivatives–assets, at fair value |  | 170 |  |  | 621,502 |  |  | 104,110 |  |  | 725,782 |
Liabilities: |  |  |  |  |  |  |  |
Securities sold short: |  |  |  |  |  |  |  |
U.S. Treasury securities sold short, at fair value |  | — |  |  | (22,578) |  |  | — |  |  | (22,578) |
Financial derivatives–liabilities, at fair value: |  |  |  |  |  |  |  |
TBAs |  | — |  |  | (1,363) |  |  | — |  |  | (1,363) |
Interest rate swaps |  | — |  |  | (1,595) |  |  | — |  |  | (1,595) |
Futures |  | (811) |  |  | — |  |  | — |  |  | (811) |
Credit default swaps |  | — |  |  | (1,912) |  |  | — |  |  | (1,912) |
Total financial derivatives–liabilities, at fair value |  | (811) |  |  | (4,870) |  |  | — |  |  | (5,681) |
Total U.S. Treasury securities sold short and financial derivatives–liabilities, at fair value |  | $ | (811) |  |  | $ | (27,448) |  |  | $ | — |  |  | $ | (28,259) |
December 31, 2023:
(In thousands) |  |  |  |  |  |  |  |
Description |  | Level 1 |  | Level 2 |  | Level 3 |  | Total
Assets: |  |  |  |  |  |  |  |
Securities: |  |  |  |  |  |  |  |
Agency RMBS: |  |  |  |  |  |  |  |
15-year fixed-rate mortgages |  | $ | — |  |  | $ | 27,847 |  |  | $ | — |  |  | $ | 27,847 |
20-year fixed-rate mortgages |  | — |  |  | 7,863 |  |  | — |  |  | 7,863 |
30-year fixed-rate mortgages |  | — |  |  | 670,294 |  |  | — |  |  | 670,294 |
Adjustable rate mortgages |  | — |  |  | 7,119 |  |  | — |  |  | 7,119 |
Reverse mortgages |  | — |  |  | 14,874 |  |  | — |  |  | 14,874 |
Interest only securities |  | — |  |  | 4,253 |  |  | 3,162 |  |  | 7,415 |
Non-Agency RMBS |  | — |  |  | 10,443 |  |  | 10,276 |  |  | 20,719 |
CLOs |  | — |  |  | 11,816 |  |  | 5,601 |  |  | 17,417 |
Total securities, at fair value |  | — |  |  | 754,509 |  |  | 19,039 |  |  | 773,548 |
Financial derivatives–assets, at fair value: |  |  |  |  |  |  |  |
TBAs |  | — |  |  | 654 |  |  | — |  |  | 654 |
Interest rate swaps |  | — |  |  | 71,341 |  |  | — |  |  | 71,341 |
Futures |  | 2,284 |  |  | — |  |  | — |  |  | 2,284 |
Total financial derivatives–assets, at fair value |  | 2,284 |  |  | 71,995 |  |  | — |  |  | 74,279 |
Total securities and financial derivatives–assets, at fair value |  | 2,284 |  |  | 826,504 |  |  | 19,039 |  |  | 847,827 |
Liabilities: |  |  |  |  |  |  |  |
Financial derivatives–liabilities, at fair value: |  |  |  |  |  |  |  |
TBAs |  | — |  |  | (1,876) |  |  | — |  |  | (1,876) |
Interest rate swaps |  | — |  |  | (4,758) |  |  | — |  |  | (4,758) |
Futures |  | (63) |  |  | — |  |  | — |  |  | (63) |
Credit default swaps |  | — |  |  | (632) |  |  | — |  |  | (632) |
Total financial derivatives–liabilities, at fair value |  | $ | (63) |  |  | $ | (7,266) |  |  | $ | — |  |  | $ | (7,329) |
Unobservable Input Reconciliation | The tables below include roll-forwards of the Company's financial instruments for the three-month periods ended March 31, 2025 and 2024 and the years ended December 31, 2024 and 2023 (including change in fair value), for financial instruments classified by the Company within Level 3 of the valuation hierarchy. Three-Month Period Ended March 31, 2025:
(In thousands) | CLOs |  | Corporate Debt |  | Corporate Equity |  | Agency RMBS
Beginning balance—December 31, 2024 | $ | 103,624 |  |  | $ | 428 |  |  | $ | 56 |  |  | $ | 2 |
Purchases | 51,769 |  |  | 12 |  |  | — |  |  | — |
Proceeds from sales | (17,517) |  |  | (13) |  |  | — |  |  | — |
(Amortization)/accretion, net | (1,464) |  |  | — |  |  | — |  |  | — |
Net realized gains (losses) | (201) |  |  | — |  |  | — |  |  | — |
Change in net unrealized gains (losses) | (8,988) |  |  | 7 |  |  | — |  |  | — |
Transfers: |  |  |  |  |  |  |
Transfers into level 3 | 16,155 |  |  | — |  |  | — |  |  | — |
Transfers out of level 3 | (9,955) |  |  | — |  |  | — |  |  | — |
Ending balance—March 31, 2025 | $ | 133,423 |  |  | $ | 434 |  |  | $ | 56 |  |  | $ | 2 |
All amounts of net realized and changes in net unrealized gains (losses) in the table above are reflected in the accompanying Consolidated Statement of Operations. The table above incorporates changes in net unrealized gains (losses) for both Level 3 financial instruments held by the Company at March 31, 2025, as well as Level 3 financial instruments disposed of by the Company during the three-month period ended March 31, 2025. For Level 3 financial instruments held by the Company as of March 31, 2025, change in net unrealized gains (losses) of $(9.5) million, $7 thousand, and $(1) thousand for the three-month period ended March 31, 2025 relate to CLOs, corporate debt, and corporate equity, respectively. At March 31, 2025, the Company transferred $10.0 million of assets from Level 3 to Level 2 and $16.2 million of assets from Level 2 to Level 3. Transfers between hierarchy levels are based on the availability of sufficient observable inputs to meet Level 2 versus Level 3 criteria. The level designation of each financial instrument is reassessed at the end of each period, and is based on pricing information received from third party pricing sources. Three-Month Period Ended March 31, 2024 (unaudited):
(In thousands) | CLOs |  | Non-Agency RMBS |  | Agency RMBS
Beginning balance—December 31, 2023 | $ | 5,601 |  |  | $ | 10,276 |  |  | $ | 3,162 |
Purchases | 16,952 |  |  | — |  |  | — |
Proceeds from sales | — |  |  | — |  |  | (263) |
Principal repayments | (1,620) |  |  | (13) |  |  | — |
(Amortization)/accretion, net | (34) |  |  | (258) |  |  | (180) |
Net realized gains (losses) | 34 |  |  | 42 |  |  | 20 |
Change in net unrealized gains (losses) | (379) |  |  | 491 |  |  | 179 |
Transfers: |  |  |  |  |
Transfers into level 3 | 6,456 |  |  | 1,811 |  |  | 1,002 |
Transfers out of level 3 | (1,414) |  |  | (6,521) |  |  | — |
Ending balance—March 31, 2024 | $ | 25,596 |  |  | $ | 5,828 |  |  | $ | 3,920 |
All amounts of net realized and changes in net unrealized gains (losses) in the table above are reflected in the accompanying Consolidated Statement of Operations. The table above incorporates changes in net unrealized gains (losses) for both Level 3 financial instruments held by the Company as of March 31, 2024, as well as Level 3 financial instruments disposed of by the Company during the three-month period ended March 31, 2024. For Level 3 financial instruments held by the Company as of March 31, 2024, change in net unrealized gains (losses) of $0.4 million, $0.1 million, and $0.2 million for the three-month period ended March 31, 2024 relate to CLOs, non-Agency RMBS, and Agency RMBS, respectively. At March 31, 2024, the Company transferred $7.9 million of assets from Level 3 to Level 2 and $9.3 million of assets from Level 2 to Level 3. Transfers between these hierarchy levels are based on the availability of sufficient observable inputs to meet Level 2 versus Level 3 criteria. The level designation of each financial instrument is reassessed at the end of each period, and is based on pricing information received from third party pricing sources. Year Ended December 31, 2024:
(In thousands) | CLOs |  | Corporate Debt |  | Corporate Equity |  | Agency RMBS |  | Non-Agency RMBS
Beginning balance as of December 31, 2023 | $ | 5,601 |  |  | $ | — |  |  | $ | — |  |  | $ | 3,162 |  |  | $ | 10,276 |
Purchases | 179,444 |  |  | 400 |  |  | 75 |  |  | — |  |  | — |
Proceeds from sales | (42,997) |  |  | (5) |  |  | — |  |  | (3,010) |  |  | (10,898) |
(Amortization)/accretion, net | (3,045) |  |  | — |  |  | — |  |  | (437) |  |  | (428) |
Net realized gains (losses) | 1,145 |  |  | 3 |  |  | — |  |  | 727 |  |  | 3,403 |
Change in net unrealized gains (losses) | (6,767) |  |  | 30 |  |  | (19) |  |  | (440) |  |  | (2,353) |
Transfers: |  |  |  |  |  |  |  |  |
Transfers into level 3 | 14,566 |  |  | — |  |  | — |  |  | — |  |  | — |
Transfers out of level 3 | (44,323) |  |  | — |  |  | — |  |  | — |  |  | — |
Ending balance as of December 31, 2024 | $ | 103,624 |  |  | $ | 428 |  |  | $ | 56 |  |  | $ | 2 |  |  | $ | — |
All amounts of net realized and changes in net unrealized gains (losses) in the table above are reflected in the accompanying Consolidated Statement of Operations. The table above incorporates changes in net unrealized gains (losses) for both Level 3 financial instruments held by the Company at December 31, 2024, as well as Level 3 financial instruments disposed of by the Company during the year ended December 31, 2024. For Level 3 financial instruments held by the Company as of December 31, 2024, change in net unrealized gains (losses) of $(6.0) million, $30 thousand, and $(19) thousand for the year ended December 31, 2024 relate to CLOs, corporate debt, and corporate equity, respectively. At December 31, 2024, the Company transferred $44.3 million of assets from Level 3 to Level 2 and $14.6 million of assets from Level 2 to Level 3. Transfers between hierarchy levels are based on the availability of sufficient observable inputs to meet Level 2 versus Level 3 criteria. The level designation of each financial instrument is reassessed at the end of each period, and is based on pricing information received from third party pricing sources. Year Ended December 31, 2023:
(In thousands) | Non-Agency RMBS |  | Agency RMBS |  | CLOs
Beginning balance as of December 31, 2022 | $ | 11,834 |  |  | $ | 4,085 |  |  | $ | — |
Purchases | 4,141 |  |  | — |  |  | 5,465 |
Proceeds from sales | (5,058) |  |  | (1,484) |  |  | — |
Principal repayments | (226) |  |  | (382) |  |  | — |
(Amortization)/accretion, net | (379) |  |  | (653) |  |  | 102 |
Net realized gains (losses) | (228) |  |  | (217) |  |  | — |
Change in net unrealized gains (losses) | 799 |  |  | 276 |  |  | 34 |
Transfers: |  |  |  |  |
Transfers into level 3 | — |  |  | 1,848 |  |  | — |
Transfers out of level 3 | (607) |  |  | (311) |  |  | — |
Ending balance as of December 31, 2023 | $ | 10,276 |  |  | $ | 3,162 |  |  | $ | 5,601 |
All amounts of net realized and changes in net unrealized gains (losses) in the table above are reflected in the accompanying Consolidated Statement of Operations. The table above incorporates changes in net unrealized gains (losses) for both Level 3 financial instruments held by the Company as of December 31, 2023, as well as Level 3 financial instruments disposed of by the Company during the year ended December 31, 2023. For Level 3 financial instruments held by the Company as of December 31, 2023, change in net unrealized gains (losses) of $0.4 million, $0.6 million, and $34 thousand for the year ended December 31, 2023 relate to non-Agency RMBS, Agency RMBS, and CLOs, respectively. At December 31, 2023, the Company transferred $0.9 million of assets from Level 3 to Level 2 and $1.8 million of assets from Level 2 to Level 3. Transfers between these hierarchy levels are based on the availability of sufficient observable inputs to meet Level 2 versus Level 3 criteria. The level designation of each financial instrument is reassessed at the end of each period, and is based on pricing information received from third party pricing sources.
Quantitative Information | The following table identifies the significant unobservable inputs that affect the valuation of the Company's Level 3 financial instruments as of March 31, 2025:
|  | Range |  |
Description |  | Fair Value |  | Valuation Technique |  | Significant Unobservable Input |  | Min |  | Max |  | Weighted Average(1)
|  | (In thousands) |  |  |  |  |  |  |  |  |  |
CLOs |  | $ | 73,807 |  |  | Market quotes |  | Non-Binding Third-Party Valuation |  | $5.00 |  | $100.75 |  | $61.98
|  | 59,616 |  |  | Discounted Cash Flows |  |  |  |  |  |  |  |
|  | 133,423 |  |  |  |  | Yield(2) |  | 3.5% |  | 76.2% |  | 16.3%
Agency RMBS–Interest Only Securities |  | 2 |  |  | Option Adjusted Spread ("OAS") |  | LIBOR OAS(3) |  | 1,007 |  | 1,007 |  | 1,007
Corporate equity |  | 56 |  |  | Discounted Cash Flows |  | Yield |  | 18.5% |  | 22.6% |  | 20.2%
Corporate debt |  | 434 |  |  | Discounted Cash Flows |  | Yield |  | 8.7% |  | 43.4% |  | 16.6%
(1)Averages are weighted based on the fair value of the related instrument. (2)Excludes $1.3 million of CLOs which have estimated yields greater than 100%. Including such positions our weighted average yield would be 18.1%. (3)Shown in basis points.
Fair Value, Other Financial Instruments | The following table summarizes the estimated fair value of all other financial instruments not included in the disclosures above as of March 31, 2025 and December 31, 2024 and 2023:
| March 31, 2025 |  | December 31, 2024 |  | December 31, 2023
(In thousands) | Fair Value |  | Carrying Value |  | Fair Value |  | Carrying Value |  | Fair Value |  | Carrying Value
Assets: |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents | $ | 17,375 |  |  | $ | 17,375 |  |  | $ | 31,840 |  |  | $ | 31,840 |  |  | $ | 38,533 |  |  | $ | 38,533 |
Due from brokers | 4,308 |  |  | 4,308 |  |  | 21,517 |  |  | 21,517 |  |  | 3,245 |  |  | 3,245 |
Reverse repurchase agreements | — |  |  | — |  |  | 23,000 |  |  | 23,000 |  |  | — |  |  | — |
Liabilities: |  |  |  |  |  |  |  |  |  |  |
Repurchase agreements | 517,538 |  |  | 517,538 |  |  | 562,974 |  |  | 562,974 |  |  | 729,543 |  |  | 729,543 |
Due to brokers | 914 |  |  | 914 |  |  | 30,671 |  |  | 30,671 |  |  | 54,476 |  |  | 54,476 |
Cash and cash equivalents includes cash held in interest bearing overnight accounts, for which fair value equals the carrying value, and cash held in money market accounts, which are liquid in nature and for which fair value equals the carrying value; such assets are considered Level 1 assets. Due from brokers and Due to brokers include collateral transferred to or received from counterparties, along with receivables and payables for open and/or closed derivative positions. These receivables and payables are short term in nature and any collateral transferred consists primarily of cash; fair value of these items approximates carrying value and such items are considered Level 1 assets and liabilities. The Company's repurchase and reverse repurchase agreements are carried at cost, which approximates fair value due to their short term nature. Repurchase agreements and reverse repurchase agreements are classified as Level 2 assets and liabilities based on the adequacy of the collateral and their short term nature.

X
- Definition Tabular disclosure of financial instrument measured at fair value on recurring or nonrecurring basis. Includes, but is not limited to, instrument classified in shareholders' equity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 3: http://www.xbrl.org/2003/role/exampleRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 100 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3 + Details
Name: | us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 103 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 101 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482078/820-10-55-101 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 11 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11 + Details
Name: | us-gaap_FairValueByBalanceSheetGroupingTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration